According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...

The second executive at a drugmaker said his company was "stockpiling" in the United States, the pharma industry's biggest ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.

US pharmaceutical industry faces uncertainty with potential tariffs, impacting companies and healthcare costs, awaiting ...

The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...